Falcon Therapeutics Competitors and Similar CompaniesClear all

Falcon Therapeutics's competitors and similar companies include iBio, Century Therapeutics, Memgen and Mersana Therapeutics.

	Falcon Therapeutics Falcon Therapeutics is an early-stage cell therapy company intended to treat solid tumor cancers.	iBio iBio is a biotechnology research company.	Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer.	Memgen Memgen is a clinical-stage biotechnology company.	Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
Founding Date	Founding Date 2018	Founding Date 2008	Founding Date 2018	Founding Date 2004	Founding Date 2005
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Durham, US HQ	Locations San Diego, US HQ Bryan, US	Locations Philadelphia, US HQ Hamilton, CA Seattle, US	Locations Houston, US HQ	Locations Cambridge, US HQ
Employees	Employees 6	Employees 1630% decrease	Employees 107	Employees 7	Employees 11033% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 26.2 m	Valuation ($) 115.2 m	Valuation ($) N/A	Valuation ($) 250.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $400k (FY, 2025)	Revenue (est.) $109.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income ($9.6m) (FY, 2025)	Net income N/A	Net income ($69.2m) (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 9.3m	Total funding raised $ 410m	Total funding raised $ 8.5m	Total funding raised $ 219.5m